LXEO Lexeo Therapeutics, Inc.
$2.87
Lexeo Therapeutics, Inc. (LXEO) is confirmed to report earnings on November 16, 2026, before the market open. The consensus earnings estimate is a loss of $0.33 per share.
Lexeo Therapeutics Missed Consensus Estimates
Monday, November 16, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 16
Monday · 7:00 AM ET
Earnings Whisper
-
vs ($0.33)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$3.57
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Lexeo Therapeutics, Inc.
Lexeo Therapeutics is a New York City-based, clinical stage company dedicated to reshaping the path of genetic disease.
Sector
Healthcare
Industry
Biotechnology
Held By 2 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.